Business Description
Klaria Pharma Holding AB
ISIN : SE0007280326
Compare
Compare
Traded in other countries / regions
KLAR.Sweden6FN.Germany IPO Date
2015-10-21Description
Klaria Pharma Holding AB is engaged in the development and commercialization of pharmaceutical products in Sweden for migraine and cancer-related pain. Its operations are based on a patented drug delivery platform in the form of an alginate-based polymer film. Majority of the group's operations are conducted in Sweden.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.2 | |||||
| Debt-to-Equity | 1.47 | |||||
| Debt-to-EBITDA | 16.39 | |||||
| Interest Coverage | 0.1 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 0.89 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 42.3 | |||||
| 3-Year EPS without NRI Growth Rate | 45.6 | |||||
| 3-Year FCF Growth Rate | 64.9 | |||||
| 3-Year Book Growth Rate | -42 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.06 | |||||
| 9-Day RSI | 42.95 | |||||
| 14-Day RSI | 41.21 | |||||
| 6-1 Month Momentum % | -0.5 | |||||
| 12-1 Month Momentum % | -20.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 20.79 | |||||
| Quick Ratio | 20.79 | |||||
| Cash Ratio | 0.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -24.5 | |||||
| Shareholder Yield % | -1.65 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -17.69 | |||||
| Net Margin % | 582.62 | |||||
| FCF Margin % | -61.07 | |||||
| ROE % | -134.53 | |||||
| ROA % | -59.81 | |||||
| ROIC % | 1.75 | |||||
| ROC (Joel Greenblatt) % | 3.34 | |||||
| ROCE % | 2.77 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 2.22 | |||||
| PB Ratio | 3.3 | |||||
| Price-to-Tangible-Book | 3.3 | |||||
| Price-to-Free-Cash-Flow | 6.47 | |||||
| Price-to-Operating-Cash-Flow | 6.47 | |||||
| EV-to-EBIT | 52.66 | |||||
| EV-to-Forward-EBIT | 1.01 | |||||
| EV-to-EBITDA | 52.39 | |||||
| EV-to-Forward-EBITDA | 1.01 | |||||
| EV-to-Revenue | -8.47 | |||||
| EV-to-Forward-Revenue | 0.45 | |||||
| EV-to-FCF | 13.86 | |||||
| Price-to-Net-Current-Asset-Value | 3.3 | |||||
| Earnings Yield (Greenblatt) % | 1.9 | |||||
| FCF Yield % | 10.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Klaria Pharma Holding AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | -7.147 | ||
| EPS (TTM) (kr) | -0.37 | ||
| Beta | 0 | ||
| Volatility % | 120.87 | ||
| 14-Day RSI | 41.21 | ||
| 14-Day ATR (kr) | 0.056412 | ||
| 20-Day SMA (kr) | 0.38535 | ||
| 12-1 Month Momentum % | -20.6 | ||
| 52-Week Range (kr) | 0.14 - 1.145 | ||
| Shares Outstanding (Mil) | 129.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Klaria Pharma Holding AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Klaria Pharma Holding AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Klaria Pharma Holding AB Frequently Asked Questions
What is Klaria Pharma Holding AB(OSTO:KLAR)'s stock price today?
The current price of OSTO:KLAR is kr0.33. The 52 week high of OSTO:KLAR is kr1.15 and 52 week low is kr0.14.
When is next earnings date of Klaria Pharma Holding AB(OSTO:KLAR)?
The next earnings date of Klaria Pharma Holding AB(OSTO:KLAR) is 2025-02-28 Est..
Does Klaria Pharma Holding AB(OSTO:KLAR) pay dividends? If so, how much?
Klaria Pharma Holding AB(OSTO:KLAR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers